Trials / Completed
CompletedNCT06345638
Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to characterize sex differences in the pathophysiology of vaso-occlusive crises (VOC) occurring among individuals with sickle cell disease (SCD). * The study will compare CRP and other biomarkers between females with SCD in the follicular phase of the menstrual cycle and males with SCD. * The study will explore potential sex differences in biomarker changes between females and males with SCD during and following resolution of VOC. * The study will compare neutrophil and platelet adhesion to the endothelium and real time fibrin deposition in the blood.
Conditions
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2025-06-17
- Completion
- 2025-06-17
- First posted
- 2024-04-03
- Last updated
- 2025-08-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06345638. Inclusion in this directory is not an endorsement.